Healthy Blood Vessels — Advanced Lipid Panel With Lp(a)
This advanced lipid blood test panel measures cholesterol fractions, ApoB, Lp(a), and particle metrics to clarify atherosclerosis risk and guide next steps.
This panel bundles multiple biomarker tests in one order—your report explains how results fit together.
This is not a single cholesterol test. The Healthy Blood Vessels — Advanced Lipid Panel With Lp(a) is a bundled lab panel that looks at multiple, complementary lipid and lipoprotein markers in one blood draw so you can see whether your risk is being driven by “how much” atherogenic cholesterol you carry, “how it’s packaged” (particle measures), and whether inherited Lp(a) is adding extra risk.
Do I need this panel?
You may want this lab panel if you have a personal or family history of early heart attack, stroke, or peripheral artery disease, especially when a standard lipid panel looks “fine” but your risk story does not. This panel is also useful if you have diabetes, metabolic syndrome, fatty liver, chronic kidney disease, inflammatory conditions, or you are post-menopausal—situations where LDL cholesterol (LDL-C) can underestimate the number of atherogenic particles.
You may also benefit if you are already on lipid-lowering therapy (such as a statin, ezetimibe, bempedoic acid, or a PCSK9 inhibitor) and you want to confirm that treatment is lowering the marker most closely tied to plaque formation (often ApoB or LDL particle number), not just shifting cholesterol between fractions.
If you have been told your Lp(a) is high—or you are worried it might be because of family history—this panel helps you separate inherited risk (Lp(a) tends to be genetically determined) from modifiable risk (ApoB/LDL-P, triglycerides, and related ratios). Testing supports clinician-directed care and shared decision-making; it is not a diagnosis by itself.
Some values in advanced lipid testing may be calculated or derived (for example, non-HDL cholesterol or ratios), and reference ranges can vary by lab and method.
Lab testing
Order the Advanced Lipid Panel With Lp(a)
Schedule online, results typically within about a week
Clear reporting and optional clinician context
HSA/FSA eligible where applicable
Get this panel with Vitals Vault
Vitals Vault makes it straightforward to order an advanced lipid lab panel that includes Lp(a) without having to piece together separate tests. You get a single set of results that you can review as a pattern—ApoB and particle measures alongside standard cholesterol numbers—so the “lipid jargon” becomes a clearer story.
After your results are in, you can use PocketMD to ask practical questions like: “Is my LDL-C low but ApoB still high?”, “Does my Lp(a) change what target I should aim for?”, or “How often should I repeat this panel after a medication or lifestyle change?” This is especially helpful if you are deciding whether to intensify therapy, focus on triglyceride/insulin resistance patterns, or prioritize blood pressure, smoking cessation, sleep apnea treatment, and other non-lipid drivers.
If you are tracking progress, repeating the same panel over time can help you see whether changes are moving the markers that matter most for plaque risk, not just the ones that look good on a basic report.
- One blood draw, multiple complementary lipid and lipoprotein markers
- Designed for pattern-based interpretation (ApoB/LDL-P, triglycerides, HDL metrics, and Lp(a))
- PocketMD support to translate results into next-step questions for your clinician
- Useful for baseline testing and for monitoring response to therapy over time
Key benefits of Healthy Blood Vessels — Advanced Lipid Panel With Lp(a)
- Clarifies atherosclerosis risk by looking beyond LDL-C to ApoB and particle measures.
- Identifies whether elevated Lp(a) may be contributing inherited, harder-to-modify risk.
- Helps explain “discordance” patterns (for example, normal LDL-C with high ApoB/LDL-P).
- Supports medication monitoring by showing whether therapy is lowering atherogenic particle burden.
- Adds context for triglyceride-driven risk patterns linked to insulin resistance and fatty liver.
- Improves conversations about targets and intensity of prevention when family history is strong.
- Creates a consistent baseline you can retest to track meaningful change over time.
What is the Healthy Blood Vessels — Advanced Lipid Panel With Lp(a) panel?
This lab panel is a bundled set of blood tests that measure different ways lipids and lipoproteins travel in your bloodstream. A standard lipid panel reports total cholesterol, LDL cholesterol (LDL-C), HDL cholesterol (HDL-C), and triglycerides. Those numbers are useful, but they do not always reflect how many atherogenic particles are circulating or whether you have additional inherited risk from lipoprotein(a) (Lp(a)).
An advanced lipid panel adds markers such as apolipoprotein B (ApoB) and LDL particle number (often reported as LDL-P). These are closer to “particle burden”—how many ApoB-containing particles (like LDL and remnant particles) can enter the artery wall and contribute to plaque. In many people, especially those with insulin resistance, LDL-C can look acceptable while particle burden remains high.
The panel also includes Lp(a), a genetically influenced lipoprotein that resembles LDL but carries an additional protein (apolipoprotein(a)). Lp(a) can increase cardiovascular risk independent of LDL-C, and it often does not respond much to lifestyle changes. Knowing your Lp(a) helps you and your clinician decide how aggressively to manage the modifiable parts of risk.
Because this is a panel, the most useful interpretation comes from looking at the pattern: LDL-C versus ApoB/LDL-P, triglycerides and HDL metrics, and whether Lp(a) is adding an extra layer of risk that changes your prevention strategy.
What do my panel results mean?
Lower-risk pattern across the panel
A lower-risk pattern often looks like low ApoB and/or low LDL particle number alongside favorable triglycerides and non-HDL cholesterol. In this pattern, LDL-C, non-HDL-C, ApoB, and particle metrics generally agree (they are not “discordant”), suggesting fewer atherogenic particles are circulating. If Lp(a) is low, that usually means you do not have that inherited risk amplifier; if Lp(a) is high but the rest of the panel is well-controlled, it can still be reassuring because you are minimizing the modifiable contributors to plaque.
Optimal pattern (aligned markers and clear targets)
An optimal pattern is when the core atherogenic markers point in the same direction: LDL-C and non-HDL-C are controlled, ApoB (or LDL-P) is at a clinician-agreed goal, and triglycerides are not elevated. HDL-related measures may look supportive (not necessarily “high,” but consistent with good metabolic health). If Lp(a) is elevated, an “optimal” pattern usually means your modifiable markers are being managed more tightly to offset inherited risk, and your plan may emphasize consistent therapy and long-term trend monitoring rather than one-time numbers.
Higher-risk pattern (particle burden, remnants, or Lp(a) driving risk)
A higher-risk pattern can show up in a few common ways. One is elevated ApoB and/or LDL-P even when LDL-C is only mildly elevated—this suggests more atherogenic particles than LDL-C alone implies. Another is a triglyceride-forward pattern (higher triglycerides with lower HDL metrics), which can reflect insulin resistance and increased remnant particles that also carry ApoB. A third is markedly elevated Lp(a), which can raise risk even if other markers are reasonable; in that case, the panel helps you see whether you also need to intensify modifiable targets (often ApoB/non-HDL-C) and address other risk factors like blood pressure, smoking, sleep apnea, and inflammation.
Factors that influence advanced lipid and Lp(a) results
Your results can shift based on recent diet, alcohol intake, weight change, illness, and how consistently you take medications. Triglycerides are especially sensitive to recent meals, alcohol, and carbohydrate intake, so fasting status can matter depending on what your clinician is evaluating. ApoB and LDL-P often respond to statins, ezetimibe, bempedoic acid, and PCSK9 inhibitors, while Lp(a) is largely genetic and tends to be relatively stable over time (though values can vary somewhat by assay). Thyroid status, kidney disease, pregnancy, menopause/hormone therapy, and uncontrolled diabetes can also change lipid patterns. If your panel shows “discordance” (LDL-C not matching ApoB/LDL-P), it is a signal to interpret the panel as a whole rather than anchoring on a single familiar number.
What’s included in this panel
- Lipoprotein (A)
- Cholesterol, Total
- Hdl Cholesterol
- Triglycerides
- Ldl-Cholesterol
- Chol/Hdlc Ratio
- Ldl/Hdl Ratio
- Non Hdl Cholesterol
- Apolipoprotein B
- Ldl Particle Number
- Ldl Small
- Ldl Medium
- Hdl Large
- Ldl Pattern
- Ldl Peak Size
Frequently Asked Questions
Do I need to fast for this advanced lipid panel?
Fasting can be helpful when triglycerides and remnant-related markers are a key focus, because triglycerides can rise after eating. Many lipid tests can still be interpreted without fasting, but if you want the cleanest triglyceride and remnant picture, ask your clinician whether an 8–12 hour fast is appropriate for you and follow the collection instructions provided with your order.
Why can my LDL-C be normal but ApoB or LDL-P be high?
LDL-C reflects how much cholesterol is carried inside LDL particles, not how many particles you have. If you have many cholesterol-poor particles (a common pattern with insulin resistance), LDL-C can look “okay” while ApoB or LDL-P is elevated. ApoB and LDL-P are closer to particle count, which is why this panel is useful when your risk factors and your basic lipid panel do not match.
If my Lp(a) is high, can I lower it with diet and exercise?
Lp(a) is largely inherited and tends to be relatively stable across your life. Healthy lifestyle still matters a lot, but it may not meaningfully lower Lp(a) itself. The practical value of knowing Lp(a) is that it can justify tighter control of modifiable risk factors—often lowering ApoB/non-HDL-C more aggressively and addressing blood pressure, smoking, sleep apnea, and metabolic health.
How often should I repeat this panel?
It depends on what you are changing. After starting or adjusting lipid-lowering therapy, many clinicians recheck key markers in about 6–12 weeks to confirm response and adherence. If you are stable, repeating every 6–12 months is common for monitoring. Lp(a) often does not need frequent repeats because it is mostly genetic, but it may be rechecked if your lab uses a different method or if your clinician wants confirmation.
Is this panel better than a standard lipid panel?
It is more detailed, not automatically “better” for everyone. A standard lipid panel is a good screening tool and is often enough for low-risk people. This advanced panel is most helpful when you have higher baseline risk, strong family history, metabolic risk factors, or you want to verify that treatment is lowering atherogenic particle burden (ApoB/LDL-P) and to understand whether Lp(a) is adding inherited risk.
Should I order this panel or order individual tests separately?
Ordering a bundled panel is usually simpler because it captures the markers that are meant to be interpreted together (LDL-C, non-HDL-C, ApoB/LDL-P, triglycerides, and Lp(a)). Ordering individual tests can make sense if you are doing a targeted follow-up (for example, rechecking ApoB after a medication change). If you are unsure, PocketMD can help you think through which approach matches your goal.